Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Unresectable Locally Recurrent Breast Cancer × trastuzumab deruxtecan × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 2 Neoplasms 2 Breast Cancer With Brain Metastasis 2 Unresectable Locally Recurrent Breast Cancer 1 HER2 Overexpression 1 Colorectal Neoplasms 1 Brain Neoplasms 1 Advanced Solid Tumor 1

Interventions

trastuzumab deruxtecan 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07497386 2026-03-27

A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Not yet recruiting

Unresectable Locally Recurrent Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡